Class information for:
Level 1: SULOFENUR//INDISULAM//E7070

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25516 279 27.3 69%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
5 4 CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY 1745167
9 3       CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII 135847
3060 2             SULTAMS//BETA SULTAMS//SULTONES 2438
25516 1                   SULOFENUR//INDISULAM//E7070 279

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SULOFENUR authKW 1233081 5% 87% 13
2 INDISULAM authKW 681924 3% 69% 9
3 E7070 authKW 633213 3% 64% 9
4 CHEM TECHNOL DRUGS address 551146 14% 13% 39
5 2 MERCAPTOBENZENESULFONAMIDE authKW 547227 2% 100% 5
6 LY295501 authKW 437782 1% 100% 4
7 N 1 SULFONYLCYTOSINE DERIVATIVES authKW 437782 1% 100% 4
8 4 PHENYL 1 ARYLSULFONYLIMIDAZOLIDINONE authKW 328336 1% 100% 3
9 CHLOROQUINOXALINE SULFONAMIDE authKW 328336 1% 100% 3
10 DW2282 authKW 328336 1% 100% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Chemistry, Medicinal 2320 27% 0% 76
2 Oncology 732 28% 0% 77
3 Pharmacology & Pharmacy 700 30% 0% 85
4 Chemistry, Organic 259 15% 0% 42
5 Chemistry, Multidisciplinary 85 14% 0% 39
6 Crystallography 42 4% 0% 11
7 Biochemical Research Methods 6 3% 0% 7
8 Spectroscopy 4 2% 0% 5
9 Biochemistry & Molecular Biology 4 8% 0% 23
10 Chemistry, Analytical 2 3% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CHEM TECHNOL DRUGS 551146 14% 13% 39
2 BETA SECT DRUG TOXICOL 109445 0% 100% 1
3 BIOMED ANALBETA 109445 0% 100% 1
4 BIOMOL INTERACT SPECT 109445 0% 100% 1
5 CENTRO MTS 109445 0% 100% 1
6 KAISER FRANZ JOSEFSPITAL 109445 0% 100% 1
7 ONCOL HAEMTOL 109445 0% 100% 1
8 TSUKUBA EXPLORATORY S DRUG DISCOVERY 109445 0% 100% 1
9 SECT DRUG TOXICOL 109437 2% 20% 5
10 SEEDS FINDING TECHNOL 75995 2% 14% 5

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INVESTIGATIONAL NEW DRUGS 10969 6% 1% 16
2 CANCER COMMUNICATIONS 4288 1% 2% 2
3 POLISH JOURNAL OF CHEMISTRY 4010 5% 0% 14
4 ARCHIVES OF PHARMACAL RESEARCH 2752 4% 0% 10
5 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2631 5% 0% 15
6 ANTI-CANCER DRUGS 2136 3% 0% 8
7 JOURNAL OF THE INSTITUTION OF BRITISH TELECOMMUNICATIONS ENGINEERS 1518 0% 1% 1
8 ACTA POLONIAE PHARMACEUTICA 1217 1% 0% 4
9 JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 741 1% 0% 2
10 CANCER CHEMOTHERAPY AND PHARMACOLOGY 721 3% 0% 7

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 SULOFENUR 1233081 5% 87% 13 Search SULOFENUR Search SULOFENUR
2 INDISULAM 681924 3% 69% 9 Search INDISULAM Search INDISULAM
3 E7070 633213 3% 64% 9 Search E7070 Search E7070
4 2 MERCAPTOBENZENESULFONAMIDE 547227 2% 100% 5 Search 2+MERCAPTOBENZENESULFONAMIDE Search 2+MERCAPTOBENZENESULFONAMIDE
5 LY295501 437782 1% 100% 4 Search LY295501 Search LY295501
6 N 1 SULFONYLCYTOSINE DERIVATIVES 437782 1% 100% 4 Search N+1+SULFONYLCYTOSINE+DERIVATIVES Search N+1+SULFONYLCYTOSINE+DERIVATIVES
7 4 PHENYL 1 ARYLSULFONYLIMIDAZOLIDINONE 328336 1% 100% 3 Search 4+PHENYL+1+ARYLSULFONYLIMIDAZOLIDINONE Search 4+PHENYL+1+ARYLSULFONYLIMIDAZOLIDINONE
8 CHLOROQUINOXALINE SULFONAMIDE 328336 1% 100% 3 Search CHLOROQUINOXALINE+SULFONAMIDE Search CHLOROQUINOXALINE+SULFONAMIDE
9 DW2282 328336 1% 100% 3 Search DW2282 Search DW2282
10 DIARYLSULFONYLUREA 318376 3% 36% 8 Search DIARYLSULFONYLUREA Search DIARYLSULFONYLUREA

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BRZOZOWSKI, Z , SLAWINSKI, J , SZAFRANSKI, K , (2014) ON THE REACTION PRODUCTS OF 4-SUBSTITUTED 3-PYRIDINESULFONAMIDES WITH SOME BENZENESULFONYL CHLORIDE DERIVATIVES.JOURNAL OF HETEROCYCLIC CHEMISTRY. VOL. 51. ISSUE 1. P. 11 -17 24 89% 0
2 BRZOZOWSKI, Z , ZOLNOWSKA, B , SLAWINSKI, J , (2013) SYNTHESIS OF A NEW SERIES OF BIOLOGICALLY INTERESTING 6 '-CHLORO-1 ',1 '-DIOXOSPIRO[4H-BENZO[D][1,3,7]OXADIAZOCINE-4,3 '(2 ' H)-[1,4,2]BENZODITHIAZINE]-2,6(1H,5H)DIONE DERIVATIVES.MONATSHEFTE FUR CHEMIE. VOL. 144. ISSUE 9. P. 1397 -1405 22 85% 1
3 BRZOZOWSKI, Z , SACZEWSKI, F , SLAWINSKI, J , (2008) SYNTHESES OF POTASSIUM 1,1-DIOXOPYRIDO[4,3-E]-1,4,2-DITHIAZINE-3-THIOLATE AND ITS APPLICATION TO THE SYNTHESIS OF NOVEL SULFONAMIDES WITH POTENTIAL BIOLOGICAL ACTIVITY.JOURNAL OF HETEROCYCLIC CHEMISTRY. VOL. 45. ISSUE 5. P. 1407 -1413 21 91% 2
4 OWA, T , NAGASU, T , (2000) NOVEL SULPHONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 10. ISSUE 11. P. 1725 -1740 37 57% 82
5 BRZOZOWSKI, Z , SLAWINSKI, J , KEDZIA, A , KWAPISZ, E , GDANIEC, M , (2009) APPLICATION OF 3-METHYLTHIOPYRIDO[4,3-E]-1,4,2-DITHIAZINE 1,1-DIOXIDE TO THE SYNTHESIS OF NOVEL SERIES OF 4H-PYRIDO[4,3-E]-1,2,4-THIADIAZINE DERIVATIVES WITH POTENTIAL BIOLOGICAL ACTIVITY.JOURNAL OF HETEROCYCLIC CHEMISTRY. VOL. 46. ISSUE 6. P. 1396 -1403 21 84% 2
6 JOCHHEIM, CM , DAVIS, MR , BAILLIE, KM , EHLHARDT, WJ , BAILLIE, TA , (2002) GLUTATHIONE-DEPENDENT METABOLISM OF THE ANTITUMOR AGENT SULOFENUR. EVIDENCE FOR THE FORMATION OF P-CHLOROPHENYL ISOCYANATE AS A REACTIVE INTERMEDIATE.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 15. ISSUE 2. P. 240 -248 27 77% 11
7 BRZOZOWSKI, Z , SLAWINSKI, J , (2007) SYNTHESIS OF 2-(4-CHLORO-2-MERCAPTOBENZENESULFONYL)-3,5-DIHYDROXY-1,1-DIOXO-2H-1,2,4,6-THIATRIAZINE DERIVATIVES WITH POTENTIAL ANTI-HIV AND ANTICANCER ACTIVITIES.POLISH JOURNAL OF CHEMISTRY. VOL. 81. ISSUE 8. P. 1419 -1426 19 86% 7
8 BRZOZOWSKI, Z , SLAWINSKI, J , (2013) SYNTHESIS OF NOVEL SERIES OF 6-CHLORO-1,1-DIOXO-1,4,2-BENZODITHIAZINE DERIVATIVES WITH POTENTIAL BIOLOGICAL ACTIVITY.JOURNAL OF HETEROCYCLIC CHEMISTRY. VOL. 50. ISSUE 5. P. 1099 -1107 15 94% 0
9 ABU-EL-HALAWA, R , MASAD, M , BATHICH, Y , AL-REFAI, M , IBRAHIM, MM , EL-ABADELAH, MM , VOELTER, W , (2011) CONCISE SYNTHESIS AND DISPLACEMENT REACTIONS OF MODEL 3-(ALKYLTHIO)-6-CHLORO- AND 2,6-DICHLOROTHIENO[2,3-E][1,4,2]DITHIAZINE 1,1-DIOXIDES.ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES. VOL. 66. ISSUE 7. P. 715 -720 14 100% 0
10 BRZOZOWSKI, Z , SLAWINSKI, J , SACZEWSKI, F , SANCHEZ, T , NEAMATI, N , (2008) SYNTHESIS, ANTI-HIV-1 INTEGRASE, AND CYTOTOXIC ACTIVITIES OF 4-CHLORO-N-(4-OXOPYRIMIDIN-2-YL)-2-MERCAPTOBENZENESULFONAMIDE DERIVATIVES.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 43. ISSUE 6. P. 1188 -1198 17 85% 10

Classes with closest relation at Level 1


Rank Class id link
1 27606 DRUG RADIAT//M PRC//ANTI BREAST CANCER ACTIVITY
2 24238 SULFONYL CHLORIDES//4 CHLOROBENZENESULFONYL CHLORIDE//ENZYME INHIBITION ACTIVITY
3 5476 COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS
4 2987 CHIM BIOINORGAN//CARBONIC ANHYDRASE//POLO SCI
5 13838 PHENOXODIOL//NADH OXIDASE//PLASMA MEMBRANE REDOX SYSTEM
6 27571 PHARMACODYNAM THER EUT//PHARMACODYNAMIE THER EUT//SERV CHIM PHARMACEUT
7 19617 SULFATHIAZOLE COMPLEXES//N SUBSTITUTED SULFONAMIDES//SULFONAMIDE LIGANDS
8 21112 PAULLONES//ADV BIOINFORMAT SYST MED//NCI 60
9 26683 HETEROCYCL CPDS//N ACYLSULFONAMIDE//N ACYLBENZOTRIAZOLES
10 31812 CHANGROLIN//SULCARDINE SULFATE//1 2 3 7 TETRAHYDRO1 3OXAZINO5 6 EINDOLE 9 CARBOXYLATES

Go to start page